Adenosine: a new drug for acute termination of supraventricular tachycardia.
Where this comes from
- Record sourced from PubMed, PMID 2364537.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Adenosine, recently released for the acute termination of supraventricular tachycardia, is potentially the drug of first choice for this indication. Its notable effects are transient slowing of the sinus rate and atrioventricular nodal block. Adverse effects are transient and clinically insignificant, primarily because of the ultra-short half-life of the drug. Preliminary investigations suggest that adenosine may also be useful in the differential diagnosis of wide QRS complex tachycardias.